ID   BALM-25
AC   CVCL_5701
DR   JCRB; JCRB1801
DR   Wikidata; Q54753199
RX   PubMed=15160921;
CC   Population: Japanese.
CC   Virology: EBV-negative.
CC   Doubling time: 30 hours (PubMed=15160921).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): JCRB=JCRB1801
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 11,12
ST   D16S539: 9,11
ST   D5S818: 12,13
ST   D7S820: 8,11
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16
DI   NCIt; C7954; Adult Burkitt leukemia
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 15
//
RX   PubMed=15160921; DOI=10.1080/10428190310001604226;
RA   Matsuo Y., Drexler H.G., Harashima A., Takenaka K., Ishihara T.,
RA   Ishimaru F., Orita K.;
RT   "A novel ALL-L3 cell line, BALM-25, expressing both immunoglobulin
RT   light chains.";
RL   Leuk. Lymphoma 45:575-581(2004).
//